MedPath

TERUMO CORPORATION

🇯🇵Japan
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

31

Active:3
Completed:23

Trial Phases

2 Phases

Phase 3:5
Not Applicable:19

Drug Approvals

15

FDA:15

Drug Approvals

  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (24 trials with phase data)• Click on a phase to view related trials

Not Applicable
19 (79.2%)
Phase 3
5 (20.8%)
No trials found

News

MedHub-AI Receives PMDA Approval for AI-Powered Coronary Assessment Technology in Japan

MedHub-AI's AutocathFFR® becomes the first fully automated AI-powered software to receive PMDA approval in Japan for calculating Fractional Flow Reserve values directly from X-ray angiograms without invasive procedures.

Terumo Neuro Launches SOFIA Flow 88 Neurovascular Aspiration Catheter in EMEA Markets

Terumo Neuro announced the commercial availability of the SOFIA Flow 88 neurovascular aspiration catheter in Europe, Middle East, and Africa markets, expanding their stroke treatment portfolio.

FDA Approves Terumo Neuro's First-in-Class Dual-Layer Micromesh Carotid Stent System

Terumo Neuro has received FDA Premarket Approval for its innovative Carotid Stent System, marking the first dual-layer micromesh carotid stent approved for use in the United States.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.